southerninjurylawyer.com Tagged Articles
when considering a Personal injury or Product liability attorney, experience and a proven track record are critical to a successful case
Beasley Allen has acquired the reputation of being one of the most successful personal injury and product liability law firms in the country. Our personal injury and product liability attorneys have built a reputation working on these types of cases. Our attorneys work closely with our support staff to provide thorough evaluations and research for each case.
personal injury experience
Some of our landmark personal injury lawsuits include a $11.75 million verdict involving the release of a prisoner who injured the plaintiff, $15 million verdict against a bar in a dram shop case, $4.2 million verdict dealing with a person falling through a skylight and a $7 million verdict involving a nursing home case.
product liability experience
Among our most important product liability lawsuits are a $150 million verdict involving a defective door latch on a major auto manufacturers SUV, $122 million verdict involving General Motors, $114.5 million verdict in an electrocution case, and a $26 million verdict involving a back up alarm system.
New website monitors how corporations, lobbyists are eroding our Constitutional rights
Alarmed by the corporate lobby’s aggressive efforts to undermine the U.S. civil justice system, the American Association for Justice (AAJ) has launched a new website and blog called Take Justice Back.
Family of deceased player Derek Boogaard sues NHL over his injuries, early death
The family of professional hockey player Derek Boogaard has filed a wrongful-death lawsuit against the National Hockey League (NHL), accusing the organization of subjecting Mr. Boogaard to severe trauma and then loading him up on potent, highly addictive prescription painkillers.
Peanut Corporation of America executive indicted by Grand Jury on charges stemming from Salmonella Outbreak
The owner of Peanut Corporation of America (PCA), where one of the deadliest Salmonella outbreaks in U.S. history originated, has been indicted by a federal Grand Jury on 76 criminal charges. A group of employees and associates of the now-defunct
Prescription drug deaths rise for 11th consecutive year
The number of prescription drug-induced deaths rose for the 11th straight year, according to a Centers for Disease Control and Prevention (CDC) analysis. Most of the drug deaths were accidents involving potent painkillers such as OxyContin and Vicodin.
Huntsville company faces steep fines, lawsuit after ordering worker into unsafe trench
HUNTSVILLE, ALA—Federal regulators are suing a Huntsville, Alabama-based house-moving company for allegedly firing one of its workers when he refused to enter a 15-foot deep trench because it was inadequately protected against cave-ins.
Toppled TV kills Arizona boy
PHOENIX, AZ – Police officials say that a 5-year old boy died in Phoenix Monday after a television set apparently fell on top of him.
Deadly Reno air crash blamed on worn lock nuts, unsafe plane modifications
A September 2011 airplane crash at a Reno, Nevada, air show that killed 11 people and injured more than 60 others was the result of worn-out and poorly maintained parts that came apart under the pressure of flying the plane
Traumatic brain injury victim on road to recovery after state fair stage collapse
A woman whose skull was crushed in the Indiana State Fair stage collapse last August is showing remarkable signs of recovery after the traumatic brain injury she received left her in a coma and on life support.
FDA advises diet drug makers to assess heart risks
Pharmaceutical companies who develop weight loss drugs need to study their medications to determine heart risks before seeking approval from health regulators, the Food and Drug Administration (FDA) said in a report released this week.
Trials on experimental type 2 diabetes drug dropped after dismal results
Pharmaceutical company Targacept, Inc. is giving up on its experimental type 2 diabetes drug known as TC-6987, after it showed less than desirable results in phase II clinical trials. The drug was designed to measure changes in fasting glucose, a